Abstract:Magnetic nanoparticles (MNPs), either paramagnetic or superparamagnetic depending on their composition and size, have been thoroughly studied as magnetic resonance imaging (MRI) contrast agents using in vitro and in vivo biomedical preclinical studies, while some are clinically used. Their magnetic properties responsible in some cases for high magnetization values, together with large surface area-to-volume ratios and the possibility of surface functionalization, have been used in MRI-based diagnostic and theranostics applications. MNPs are usually used as positive (T1) or negative (T2) MRI contrast agents, causing brightening or darkening of selected regions in MRI images, respectively. This review focusses on recent developments and optimization of MNPs containing Gd, Mn, Fe and other lanthanide ions which may function as dual-mode T1–T2 MRI contrast agents (DMCAs). They induce positive or negative contrast in the same MRI scanner upon changing its operational mode between T1-weighted and T2-weighted pulse sequences. The type of contrast they induce depends critically on their r2/r1 relaxivity ratio, which for DMCAs should be in the 2–10 range of values. After briefly discussing the basic principles of paramagnetic relaxation in MNPs, in this review, the basic strategies for the rational design of DMCAs are presented and typical examples are discussed, including in vivo preclinical applications: (1) the use of NPs with a single type of contrast material, Gd- or Mn-based NPs or superparamagnetic NPs with appropriate size and magnetization to provide T2 and T1 contrast; and (2) inclusion of both types of T1 and T2 contrast materials in the same nanoplatform by changing their relative positions.

Research progress in the design of gadolinium-based inorganic nanoparticles for magnetic resonance contrast agents

Research Progress of Magnetic Resonance Imaging Contrast Agents

Progress in research of nanomedicine-based gadolinium contrast agents for magnetic resonance imaging

The research progress of gadolinium(iii)-based macromolecular mri contrast agents

Gadolinium‐based Contrast Agents for Magnetic Resonance Cancer Imaging

The Development of Dendritic Gd-Dtpa Complexes for Mri Contrast Agents

THE RESEARCH PROGRESS OF GADOLINIUM(Ⅲ)-BASED MACROMOLECULAR MRI CONTRAST AGENTS

Advances in magnetic nanoparticle-based magnetic resonance imaging contrast agents

Engineering of Inorganic Nanoparticles As Magnetic Resonance Imaging Contrast Agents.

Gadolinium (III)-Chelated Deformable Mesoporous Organosilica Nanoparticles as Magnetic Resonance Imaging Contrast Agent.

Rational Design of Magnetic Nanoparticles as T1–T2 Dual-Mode MRI Contrast Agents

Gadolinium(III)-based Polymeric Magnetic Resonance Imaging Agents for Tumor Imaging

Research progress in bio-responsive MRI contrast agent

Gadolinium-based Nanoscale MRI Contrast Agents for Tumor Imaging

Recent progress of rare earth nanoparticles as magnetic resonance imaging contrast agents

Single-Atom Gadolinium Nano-Contrast Agents with High Stability for Tumor <i>T</i><sub>1</sub> Magnetic Resonance Imaging

Geometrical Confinement of Gadolinium Oxide Nanoparticles in Poly(ethylene Glycol)/arginylglycylaspartic Acid-Modified Mesoporous Carbon Nanospheres As an Enhanced T1 Magnetic Resonance Imaging Contrast Agent.

Preparation of Mn2+@PolyDOPA-b-polysarcosine Micelle As MRI Contrast Agent with High Longitudinal Relaxivity

Advances in the contrast agents for magnetic resonance imaging

Ultrasmall gadolinium hydrated carbonate nanoparticle: An advanced T 1 MRI contrast agent with large longitudinal relaxivity